BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces Fourth Quarter 2025 Results

Progyny (PGNY)ProgynyEarnings

Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full Year Generated Record $210.2 Million in Full Year Operating Cash Flow Returned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent Authorization Issues

Related news

PGNYProgyny2026-02-12 19:47 EST

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

TDOCTeladoc2026-02-25 21:05 EST

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

HSTMHealthStream2026-02-23 21:30 EST

HealthStream Announces Fourth Quarter & Full-Year 2025 Results

COOThe Cooper Companies2025-11-04 21:15 EST

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025

HSTMHealthStream2026-02-12 14:25 EST

HealthStream to Host Fourth Quarter & Full-Year 2025 Earnings Conference Call

FEMYFEMASYS2026-05-08 20:05 EST

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

SERASera Prognostics2026-03-18 20:05 EST

SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

COOThe Cooper Companies2025-12-04 21:15 EST

CooperCompanies Announces Fourth Quarter and Full Year 2025 Results

SERASera Prognostics2026-03-04 13:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-08-07 14:51 EST

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

Stock data

Close
30.21 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States